173 related articles for article (PubMed ID: 38482690)
1. One-Pot Microfluidics to Engineer Chitosan Nanoparticles Conjugated with Antimicrobial Peptides Using "Photoclick" Chemistry: Validation Using the Gastric Bacterium
Fonseca DR; Alves PM; Neto E; Custódio B; Guimarães S; Moura D; Annis F; Martins M; Gomes A; Teixeira C; Gomes P; Pereira RF; Freitas P; Parreira P; Martins MCL
ACS Appl Mater Interfaces; 2024 Mar; 16(12):14533-14547. PubMed ID: 38482690
[TBL] [Abstract][Full Text] [Related]
2. Grafting MSI-78A onto chitosan microspheres enhances its antimicrobial activity.
Fonseca DR; Moura A; Leiro V; Silva-Carvalho R; Estevinho BN; Seabra CL; Henriques PC; Lucena M; Teixeira C; Gomes P; Parreira P; Martins MCL
Acta Biomater; 2022 Jan; 137():186-198. PubMed ID: 34634508
[TBL] [Abstract][Full Text] [Related]
3. Engineering resveratrol-loaded chitosan nanoparticles for potential use against Helicobacter pylori infection.
Spósito L; Fonseca D; Gonçalves Carvalho S; Sábio RM; Marena GD; Bauab TM; Bagliotti Meneguin A; Parreira P; L Martins MC; Chorilli M
Eur J Pharm Biopharm; 2024 Jun; 199():114280. PubMed ID: 38588828
[TBL] [Abstract][Full Text] [Related]
4. Surface Grafted MSI-78A Antimicrobial Peptide has High Potential for Gastric Infection Management.
Parreira P; Monteiro C; Graça V; Gomes J; Maia S; Gomes P; Gonçalves IC; Martins MCL
Sci Rep; 2019 Dec; 9(1):18212. PubMed ID: 31796755
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the in vitro anti-inflammatory and anti-Helicobacter pylori activities of chitosan-based biomaterials modified with copper oxide nanoparticles.
Elmehbad NY; Mohamed NA; Abd El-Ghany NA; Abdel-Aziz MM
Int J Biol Macromol; 2023 Dec; 253(Pt 6):127277. PubMed ID: 37806410
[TBL] [Abstract][Full Text] [Related]
6. Strategies adopted by gastric pathogen Helicobacter pylori for a mature biofilm formation: Antimicrobial peptides as a visionary treatment.
Gupta N; Kumar A; Verma VK
Microbiol Res; 2023 Aug; 273():127417. PubMed ID: 37267815
[TBL] [Abstract][Full Text] [Related]
7. Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency of
Yang SJ; Huang CH; Yang JC; Wang CH; Shieh MJ
ACS Appl Mater Interfaces; 2020 Dec; 12(49):54316-54327. PubMed ID: 33236884
[No Abstract] [Full Text] [Related]
8. Antimicrobial coatings prepared from Dhvar-5-click-grafted chitosan powders.
Barbosa M; Costa F; Monteiro C; Duarte F; Martins MCL; Gomes P
Acta Biomater; 2019 Jan; 84():242-256. PubMed ID: 30528610
[TBL] [Abstract][Full Text] [Related]
9. Design and evaluation of novel pH-sensitive ureido-conjugated chitosan/TPP nanoparticles targeted to Helicobacter pylori.
Jing ZW; Jia YY; Wan N; Luo M; Huan ML; Kang TB; Zhou SY; Zhang BL
Biomaterials; 2016 Apr; 84():276-285. PubMed ID: 26851392
[TBL] [Abstract][Full Text] [Related]
10. The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection.
Gonçalves IC; Henriques PC; Seabra CL; Martins MC
Expert Rev Anti Infect Ther; 2014 Aug; 12(8):981-92. PubMed ID: 24981812
[TBL] [Abstract][Full Text] [Related]
11. Docosahexaenoic acid loaded lipid nanoparticles with bactericidal activity against Helicobacter pylori.
Seabra CL; Nunes C; Gomez-Lazaro M; Correia M; Machado JC; Gonçalves IC; Reis CA; Reis S; Martins MCL
Int J Pharm; 2017 Mar; 519(1-2):128-137. PubMed ID: 28088639
[TBL] [Abstract][Full Text] [Related]
12. Effective Treatment of
Gong H; Wang X; Hu X; Liao M; Yuan C; Lu JR; Gao L; Yan X
Biomacromolecules; 2024 Mar; 25(3):1602-1611. PubMed ID: 38323536
[No Abstract] [Full Text] [Related]
13. Genipin-cross-linked fucose-chitosan/heparin nanoparticles for the eradication of Helicobacter pylori.
Lin YH; Tsai SC; Lai CH; Lee CH; He ZS; Tseng GC
Biomaterials; 2013 Jun; 34(18):4466-79. PubMed ID: 23499480
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial and antibiofilm activity of mannose-modified chitosan/PMLA nanoparticles against multidrug-resistant Helicobacter pylori.
Arif M; Ahmad R; Sharaf M; Samreen ; Muhammad J; Abdalla M; Eltayb WA; Liu CG
Int J Biol Macromol; 2022 Dec; 223(Pt A):418-432. PubMed ID: 36356866
[TBL] [Abstract][Full Text] [Related]
15. In vitro antibacterial activity of nimbolide against Helicobacter pylori.
Wylie MR; Windham IH; Blum FC; Wu H; Merrell DS
J Ethnopharmacol; 2022 Mar; 285():114828. PubMed ID: 34763046
[TBL] [Abstract][Full Text] [Related]
16. Bacteria-targeted biomaterials: Glycan-coated microspheres to bind Helicobacter pylori.
Gonçalves IC; Magalhães A; Costa AM; Oliveira JR; Henriques PC; Gomes P; Reis CA; Martins MC
Acta Biomater; 2016 Mar; 33():40-50. PubMed ID: 26805428
[TBL] [Abstract][Full Text] [Related]
17. Development of novel pH-sensitive thiolated chitosan/PMLA nanoparticles for amoxicillin delivery to treat Helicobacter pylori.
Arif M; Dong QJ; Raja MA; Zeenat S; Chi Z; Liu CG
Mater Sci Eng C Mater Biol Appl; 2018 Feb; 83():17-24. PubMed ID: 29208276
[TBL] [Abstract][Full Text] [Related]
18. The molecular basis of inactivation of metronidazole-resistant Helicobacter pylori using polyethyleneimine functionalized zinc oxide nanoparticles.
Chakraborti S; Bhattacharya S; Chowdhury R; Chakrabarti P
PLoS One; 2013; 8(8):e70776. PubMed ID: 23951006
[TBL] [Abstract][Full Text] [Related]
19. Co-administration of amoxicillin-loaded chitosan nanoparticles and inulin: A novel strategy for mitigating antibiotic resistance and preserving microbiota balance in Helicobacter pylori treatment.
Fayed B; Jagal J; Cagliani R; Kedia RA; Elsherbeny A; Bayraktutan H; Khoder G; Haider M
Int J Biol Macromol; 2023 Dec; 253(Pt 2):126706. PubMed ID: 37673144
[TBL] [Abstract][Full Text] [Related]
20. Chitosan Inhibits
Chang SH; Hsieh PL; Tsai GJ
Mar Drugs; 2020 Oct; 18(11):. PubMed ID: 33138146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
